IRIS Accounts Production v25.1.4.42 05520846 Board of Directors 31.3.25 1.4.24 31.3.25 31.3.25 true true false true false false false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055208462024-03-31055208462025-03-31055208462024-04-012025-03-31055208462023-03-31055208462023-04-012024-03-31055208462024-03-3105520846ns15:EnglandWales2024-04-012025-03-3105520846ns14:PoundSterling2024-04-012025-03-3105520846ns10:Director12024-04-012025-03-3105520846ns10:Consolidated2025-03-3105520846ns10:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3105520846ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3105520846ns10:Consolidatedns10:SmallEntities2024-04-012025-03-3105520846ns10:Consolidatedns10:AuditExemptWithAccountantsReport2024-04-012025-03-3105520846ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3105520846ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3105520846ns10:Consolidatedns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3105520846ns10:Consolidatedns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3105520846ns10:FullAccounts2024-04-012025-03-3105520846ns5:Subsidiary12024-04-012025-03-3105520846ns5:Subsidiary22024-04-012025-03-3105520846ns5:Subsidiary32024-04-012025-03-3105520846ns10:Consolidated2024-04-012025-03-3105520846ns10:Director22024-04-012025-03-3105520846ns10:Director32024-04-012025-03-3105520846ns10:Director42024-04-012025-03-3105520846ns10:Director52024-04-012025-03-3105520846ns10:Director62024-04-012025-03-3105520846ns10:Director72024-04-012025-03-3105520846ns10:CompanySecretary12024-04-012025-03-3105520846ns10:RegisteredOffice2024-04-012025-03-3105520846ns10:Consolidated2023-04-012024-03-3105520846ns5:CurrentFinancialInstruments2025-03-3105520846ns5:CurrentFinancialInstruments2024-03-3105520846ns5:Non-currentFinancialInstruments2025-03-3105520846ns5:Non-currentFinancialInstruments2024-03-3105520846ns5:ShareCapital2025-03-3105520846ns5:ShareCapital2024-03-3105520846ns5:SharePremium2025-03-3105520846ns5:SharePremium2024-03-3105520846ns5:CapitalRedemptionReserve2025-03-3105520846ns5:CapitalRedemptionReserve2024-03-3105520846ns5:RetainedEarningsAccumulatedLosses2025-03-3105520846ns5:RetainedEarningsAccumulatedLosses2024-03-3105520846ns5:ShareCapital2023-03-3105520846ns5:RetainedEarningsAccumulatedLosses2023-03-3105520846ns5:SharePremium2023-03-3105520846ns5:CapitalRedemptionReserve2023-03-3105520846ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3105520846ns5:CapitalRedemptionReserve2023-04-012024-03-3105520846ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3105520846ns5:CapitalRedemptionReserve2024-04-012025-03-3105520846ns5:LeaseholdImprovements2024-04-012025-03-3105520846ns5:FurnitureFittings2024-04-012025-03-3105520846ns5:MotorVehicles2024-04-012025-03-3105520846ns5:ComputerEquipment2024-04-012025-03-3105520846ns5:LeaseholdImprovements2024-03-3105520846ns5:FurnitureFittings2024-03-3105520846ns5:MotorVehicles2024-03-3105520846ns5:ComputerEquipment2024-03-3105520846ns5:LeaseholdImprovements2025-03-3105520846ns5:FurnitureFittings2025-03-3105520846ns5:MotorVehicles2025-03-3105520846ns5:ComputerEquipment2025-03-3105520846ns5:LeaseholdImprovements2024-03-3105520846ns5:FurnitureFittings2024-03-3105520846ns5:MotorVehicles2024-03-3105520846ns5:ComputerEquipment2024-03-3105520846ns5:CostValuation2024-03-31055208461ns5:Subsidiary12024-04-012025-03-3105520846ns5:Subsidiary12025-03-3105520846ns5:Subsidiary12024-03-3105520846ns5:Subsidiary12023-04-012024-03-3105520846ns5:Subsidiary232024-04-012025-03-3105520846ns5:Subsidiary22025-03-3105520846ns5:Subsidiary22024-03-3105520846ns5:Subsidiary22023-04-012024-03-31055208465ns5:Subsidiary32024-04-012025-03-3105520846ns5:Subsidiary32025-03-3105520846ns5:Subsidiary32024-03-3105520846ns5:Subsidiary32023-04-012024-03-3105520846ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3105520846ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3105520846ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2025-03-3105520846ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-03-3105520846ns5:WithinOneYear2025-03-3105520846ns5:WithinOneYear2024-03-3105520846ns5:BetweenOneFiveYears2025-03-3105520846ns5:BetweenOneFiveYears2024-03-3105520846ns5:AllPeriods2025-03-3105520846ns5:AllPeriods2024-03-31
REGISTERED NUMBER: 05520846 (England and Wales)











Report of the Directors and

Unaudited

Consolidated Financial Statements

for the Year Ended 31 March 2025

for

Delphic HSE Solutions Limited

Delphic HSE Solutions Limited (Registered number: 05520846)

Contents of the Consolidated Financial Statements
for the Year Ended 31 March 2025










Page

Company Information 1

Report of the Directors 2

Consolidated Income Statement 3

Consolidated Statement of Financial Position 4

Company Statement of Financial Position 6

Consolidated Statement of Changes in Equity 8

Company Statement of Changes in Equity 9

Notes to the Consolidated Financial Statements 10


Delphic HSE Solutions Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: C I Betton
Mrs C E Betton
Mrs E Garner
R M Boughton
Dr P Leinster
Dr J Wakefield
T W Garner





SECRETARY: Mrs C E Betton





REGISTERED OFFICE: 1 Minster Court
Tuscam Way
Camberley
Surrey
GU15 3YY





REGISTERED NUMBER: 05520846 (England and Wales)





ACCOUNTANTS: Butt Miller
Chartered Accountants
1 Minster Court
Tuscam Way
Camberley
Surrey
GU15 3YY

Delphic HSE Solutions Limited (Registered number: 05520846)

Report of the Directors
for the Year Ended 31 March 2025


The directors present their report with the financial statements of the company and the group for the year ended 31 March 2025.

PRINCIPAL ACTIVITY
Delphic HSE Solutions Limited is a toxicological consultancy specialising in risk management and safety assessment. The majority of work carried out is driven by legislation and involves safety assessments of consumer, personal care and industrial products as required by legislation and all of our assessment staff are professionally qualified. The company also assesses, implements and advises on management systems designed to ensure workplace safety and that the environmental impacts are controlled and managed effectively. The client base ranges from small start up companies manufacturing personal care products, to major UK retailers and multinational companies engaged in energy and consumer goods production. Delphic HSE Solutions Limited also carries out toxicological assessment work for major international testing laboratories such as SGS, Bureau Veritas, Intertek and TUV.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

C I Betton
Mrs C E Betton
Mrs E Garner
R M Boughton
Dr P Leinster
Dr J Wakefield
T W Garner

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mrs E Garner - Director


17 September 2025

Delphic HSE Solutions Limited (Registered number: 05520846)

Consolidated Income Statement
for the Year Ended 31 March 2025

2025 2024
Notes £    £   

TURNOVER 4,901,193 4,004,481

Cost of sales (2,329,718 ) (1,971,932 )
GROSS PROFIT 2,571,475 2,032,549

Administrative expenses (2,165,583 ) (2,078,085 )
405,892 (45,536 )

Other operating income 88,834 -
OPERATING PROFIT/(LOSS) 494,726 (45,536 )

Interest receivable and similar income 4,521 5,428
499,247 (40,108 )

Interest payable and similar expenses (7,581 ) (6,039 )
PROFIT/(LOSS) BEFORE TAXATION 491,666 (46,147 )

Tax on profit/(loss) (98,001 ) (7,601 )
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

393,665

(53,748

)

Profit/(loss) attributable to:
Owners of the parent 393,665 (53,748 )

Delphic HSE Solutions Limited (Registered number: 05520846)

Consolidated Statement of Financial Position
31 March 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 7 31,850 35,368
Investments 8 - -
31,850 35,368

CURRENT ASSETS
Debtors 9 1,153,554 756,094
Cash at bank and in hand 323,603 226,153
1,477,157 982,247
CREDITORS
Amounts falling due within one year 10 (592,015 ) (345,199 )
NET CURRENT ASSETS 885,142 637,048
TOTAL ASSETS LESS CURRENT
LIABILITIES

916,992

672,416

CREDITORS
Amounts falling due after more than one
year

11

(1,667

)

(43,282

)

PROVISIONS FOR LIABILITIES (602 ) (935 )
NET ASSETS 914,723 628,199

CAPITAL AND RESERVES
Called up share capital 121 121
Share premium 47,680 47,680
Capital redemption reserve 3 3
Retained earnings 866,919 580,395
914,723 628,199

The company and the group are entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company and the group to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a) ensuring that the group keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company and the group as at the end of each financial year and of the group's profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company and the group.

Delphic HSE Solutions Limited (Registered number: 05520846)

Consolidated Statement of Financial Position - continued
31 March 2025


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2025 and were signed on its behalf by:





Mrs E Garner - Director


Delphic HSE Solutions Limited (Registered number: 05520846)

Company Statement of Financial Position
31 March 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 7 22,810 30,924
Investments 8 8,230 8,230
31,040 39,154

CURRENT ASSETS
Debtors 9 1,489,197 1,109,863
Cash at bank and in hand 273,958 162,491
1,763,155 1,272,354
CREDITORS
Amounts falling due within one year 10 (1,520,867 ) (694,379 )
NET CURRENT ASSETS 242,288 577,975
TOTAL ASSETS LESS CURRENT
LIABILITIES

273,328

617,129

CREDITORS
Amounts falling due after more than one
year

11

(1,667

)

(43,282

)

PROVISIONS FOR LIABILITIES (602 ) (935 )
NET ASSETS 271,059 572,912

CAPITAL AND RESERVES
Called up share capital 121 121
Share premium 47,680 47,680
Capital redemption reserve 3 3
Retained earnings 223,255 525,108
271,059 572,912

Company's (loss)/profit for the financial year (198,875 ) 35,870

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Delphic HSE Solutions Limited (Registered number: 05520846)

Company Statement of Financial Position - continued
31 March 2025


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2025 and were signed on its behalf by:





Mrs E Garner - Director


Delphic HSE Solutions Limited (Registered number: 05520846)

Consolidated Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 April 2023 121 722,292 47,680 3 770,096

Changes in equity
Dividends - (74,628 ) - - (74,628 )
Total comprehensive income - (53,748 ) - - (53,748 )
Foreign currencies translation
exchange differences
on consolidation - (13,521 ) - - (13,521 )
Balance at 31 March 2024 121 580,395 47,680 3 628,199

Changes in equity
Dividends - (102,978 ) - - (102,978 )
Total comprehensive income - 393,665 - - 393,665
Foreign currencies translation
exchange differences
on consolidation - (4,163 ) - - (4,163 )
Balance at 31 March 2025 121 866,919 47,680 3 914,723

Delphic HSE Solutions Limited (Registered number: 05520846)

Company Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 April 2023 121 563,866 47,680 3 611,670

Changes in equity
Dividends - (74,628 ) - - (74,628 )
Total comprehensive income - 35,870 - - 35,870
Balance at 31 March 2024 121 525,108 47,680 3 572,912

Changes in equity
Dividends - (102,978 ) - - (102,978 )
Total comprehensive income - (198,875 ) - - (198,875 )
Balance at 31 March 2025 121 223,255 47,680 3 271,059

Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements
for the Year Ended 31 March 2025


1. STATUTORY INFORMATION

Delphic HSE Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The consolidated accounts incorporate the accounts of all subsidiary undertakings made up to the statement of financial position date prepared in accordance with the group's accounting policies; with the exception of Delphic HSE Pty Ltd, a dormant company registered in Australia, for which no accounts have been prepared or filed.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Turnover
Turnover represent net invoiced sales of services, excluding value added tax.

Turnover represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the value due. Where a contract has only been partially completed at the statement of financial position date, turnover represents the value of the service provided to date based on a proportion of the total expected consideration at completion.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 20% on cost
Fixtures and fittings - 25% on cost and 20% on cost
Motor vehicles - 25% on cost
Computer equipment - 33.33% on cost and 20% on cost

Government grants
Grants comprise amounts received and are recognised in the Income Statement once the relevant performance conditions have been met.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Operating leases
Rentals paid under operating leases are charged to the Consolidated Income Statement on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The parent company operates a defined contribution pension scheme. Contributions payable to the parent company's pension scheme are charged to the Consolidated Income Statement in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 55 (2024 - 56 ) .

4. AUDITORS' REMUNERATION

The auditors' remuneration of £2,692 (2024: £7,096) relates to the Hong Kong subsidiary only.

5. EXCEPTIONAL ITEMS
2025 2024
£    £   
Software development (142,872 ) (122,946 )

The above items are included within the operating profit of the parent company but are deemed to be one-off costs.

6. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the income statement of the parent company is not presented as part of these financial statements.

Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


7. TANGIBLE FIXED ASSETS

Group
Improvements Fixtures
to and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 42,513 33,971 351 60,361 137,196
Additions - 2,755 - 7,242 9,997
Disposals - - - (1,616 ) (1,616 )
Exchange differences (145 ) (251 ) - (760 ) (1,156 )
At 31 March 2025 42,368 36,475 351 65,227 144,421
DEPRECIATION
At 1 April 2024 15,330 33,102 350 53,046 101,828
Charge for year 6,783 1,028 - 5,626 13,437
Eliminated on disposal - - - (1,616 ) (1,616 )
Exchange differences (145 ) (241 ) - (692 ) (1,078 )
At 31 March 2025 21,968 33,889 350 56,364 112,571
NET BOOK VALUE
At 31 March 2025 20,400 2,586 1 8,863 31,850
At 31 March 2024 27,183 869 1 7,315 35,368

Company
Improvements Fixtures
to and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 33,917 19,084 351 29,966 83,318
Additions - 821 - - 821
Disposals - - - (1,616 ) (1,616 )
At 31 March 2025 33,917 19,905 351 28,350 82,523
DEPRECIATION
At 1 April 2024 6,733 18,822 350 26,489 52,394
Charge for year 6,784 178 - 1,973 8,935
Eliminated on disposal - - - (1,616 ) (1,616 )
At 31 March 2025 13,517 19,000 350 26,846 59,713
NET BOOK VALUE
At 31 March 2025 20,400 905 1 1,504 22,810
At 31 March 2024 27,184 262 1 3,477 30,924

Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


8. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 April 2024
and 31 March 2025 8,230
NET BOOK VALUE
At 31 March 2025 8,230
At 31 March 2024 8,230

The group or the company's investments at the Statement of Financial Position date in the share capital of companies include the following:

Subsidiaries

Delphic HSE Solutions (HK) Limited
Registered office: Unit 210, 2/F, Building 16W, Phase Three, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong
Nature of business: Toxicology consultancy
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 1,142,199 525,698
Profit for the year 625,371 84,991

Delphic HSE (Europe) B.V.
Registered office: Lisdodde 83, 2408 LZ, Alphen aan den Rijn, Netherlands
Nature of business: Toxicology consultancy
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves (326,945 ) (355,480 )
Profit/(loss) for the year 20,684 (105,965 )

Delphic HSE Solutions LLC
Registered office: 3753 Howard Hughes Parkway, Suite 200 - 1277, Las Vegas, NV 89169, US
Nature of business: Toxicology consultancy
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves (112,073 ) (56,321 )
Loss for the year (56,902 ) (64,362 )


Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade debtors 922,568 654,409 730,488 459,234
Amounts owed by group undertakings - - 649,850 572,572
Amounts owed by related party 11,436 11,436 11,436 11,436
Other debtors 214,335 80,358 97,423 63,590
Directors' current accounts 5,215 9,891 - 3,031
1,153,554 756,094 1,489,197 1,109,863

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans and overdrafts 41,614 62,101 41,614 62,101
Trade creditors 105,409 55,880 83,548 47,133
Amounts owed to group undertakings - - 1,112,701 412,748
Tax 96,456 2,846 - 283
CT61 tax 898 899 898 899
Social security and other taxes 49,892 47,433 48,458 45,931
VAT 64,689 58,800 64,689 58,800
Other creditors 20,181 12,171 3,570 2,587
Directors' current accounts 34,232 5,849 34,233 5,849
Deferred income 13,777 - 13,777 -
Accrued expenses 164,867 99,220 117,379 58,048
592,015 345,199 1,520,867 694,379

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans - 1-2 years 1,667 43,282 1,667 43,282

12. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Non-cancellable operating leases
2025 2024
£    £   
Within one year 80,541 150,743
Between one and five years 7,931 25,957
88,472 176,700

Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


12. LEASING AGREEMENTS - continued

Company
Non-cancellable operating leases
2025 2024
£    £   
Within one year 80,541 92,451
Between one and five years 7,931 24,933
88,472 117,384

13. SECURED DEBTS

The following secured debts are included within creditors:

Group
2025 2024
£    £   
Bank loans 43,281 105,383

Barclays Bank Plc holds a debenture over the assets and liabilities of the company.

14. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
C I Betton and Mrs C E Betton
Balance outstanding at start of year (4,559 ) (6,121 )
Amounts advanced 135,920 63,474
Amounts repaid (160,731 ) (61,912 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (29,370 ) (4,559 )

Mrs E Garner
Balance outstanding at start of year 2,293 5,198
Amounts advanced 47,483 7,806
Amounts repaid (51,836 ) (10,711 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,060 ) 2,293

R M Boughton
Balance outstanding at start of year (1,290 ) (905 )
Amounts advanced 5,235 3,500
Amounts repaid (3,953 ) (3,885 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (8 ) (1,290 )

Delphic HSE Solutions Limited (Registered number: 05520846)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025


14. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

T W Garner
Balance outstanding at start of year 738 222
Amounts advanced 2,000 2,800
Amounts repaid (5,532 ) (2,284 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,794 ) 738

Dr J Wakefield
Balance outstanding at start of year 6,860 8,109
Amounts repaid (1,645 ) (1,249 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 5,215 6,860

Loans made to directors are unsecured, repayable on demand and where applicable subject to interest at the HMRC approved rate. Specific unsecured loans made to the company are subject to interest at a commercial rate.

The amount owed by Dr J Wakefield is in HK$ and represents 52,416 HK$ (2024: 67,780 HK$).